The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 04, 2025 for Hima Bindu Potluri
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.7 pts more than Nifty Microcap 250 and 2.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoter Hima Bindu Potluri has released a pledge on 1,06,20,000 equity shares of SMS Pharmaceuticals, representing 11.34% of the company's total share capital. The pledge was originally created in favor of Vistra ITCL (India) Limited as security for a loan taken by VKT Pharma Private Limited, an associate company of the promoter. After this release on November 3, 2025, her remaining pledged shares stand at 30,00,000 (3.20%), down from 1,36,20,000 (14.54%) earlier. Her total shareholding in the company remains unchanged at 1,50,08,840 shares (16.03%). No shares were bought or sold — only the encumbrance (pledge) was released, freeing up those shares.
Positive signal for shareholders — the release of pledged shares reduces the promoter's encumbered holdings significantly (from 14.54% to 3.20%), lowering the risk of forced sale or invocation. This generally improves promoter credibility and reduces overhang concerns on the stock.